Small cell lung cancer: Navigating the global clinical trial landscape
Small cell lung cancer is a fast-growing and aggressive subtype of lung cancer, accounting for approximately 10-15% of all lung…
Small cell lung cancer is a fast-growing and aggressive subtype of lung cancer, accounting for approximately 10-15% of all lung…
Randomization is crucial to reduce selection bias between participants in clinical trials. eClinical data platforms should make randomization processes more…
The pharmaceutical industry is currently experiencing a surge in novel drug candidates. These new drug approvals are leading to a…
PACE is an innovative multi-product modular automation line. This disruptive technology is making waves by creating a more agile and…
Clinical trials have always been complex, but the last five to ten years have seen an increase in complexities due…
Data centres are experiencing significant growth and transformation, driven by the demands of AI model training and deployment, which require…
As the pharmaceutical industry focuses on complex, potentially life changing biologics, lyophilization, or freeze-drying, has become essential for the successful…
Gamma delta (γδ) T cells hold significant potential for unmet medical needs. Yet they are more challenging to source than…
A target product profile (TPP) is a set of necessary attributes that the final drug product must have for the…
Establishing the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) marked a significant milestone in…